close search


Discovering targets of human immunity that block malaria transmission

 

Open to:
Honours; Masters; PhD

Vacancies:
1


PROGRAM

DISCIPLINE

HEALTH THEMES
Disease Elimination Life Sciences Malaria  

Despite numerous international efforts, the malaria burden has remained unchanged in recent years. With the emergence of drug-resistant parasites and control measures that are only partially effective, vaccines for sustained malaria elimination are urgently needed. While most vaccine research is directed at efforts to prevent clinical illness, this research aims to develop successful vaccines or other strategies that block the transmission of malaria parasites to mosquitoes, known as transmission-blocking interventions. 

During malaria, parasites replicate in the bloodstream causing clinical illness, which can be severe and fatal. Some parasites develop into specific transmissible forms that are taken up by a feeding mosquito, where they replicate, rapidly transmitting parasites throughout a population. Interestingly, individuals can develop unique antibodies to these transmissible forms after repeated infections. When a mosquito bites, these antibodies are ingested by mosquitoes and can prevent malaria parasite development within the mosquito and prevent transmission within populations. However, little is known about the specific targets and function of these antibodies; key knowledge of which are vital for the advancement of transmission-blocking vaccines as a much needed new strategy to support malaria elimination. 

The aim of this project is to identify key targets and mechanisms of antibodies that block malaria transmission to prioritise lead candidates for pre-clinical vaccine evaluation. The project will utilise detailed human studies, including cohorts of individuals who were experimentally infected with malaria or naturally exposed to malaria in endemic settings. Laboratory techniques will include malaria parasite culture, functional antibody assays, mosquito feeding assays and flow cytometry. The project will also link with our malaria vaccine program using mRNA and recombinant protein vaccine technologies. The project will be tailored to meet the students’ interests, education and training background.

Contact

Dr Jo-Anne Chan
Senior Postdoctoral Research Scientist
jo-anne.chan@burnet.edu.au

Dr Adam Thomas
Senior Postdoctoral Research Scientist
Malaria Immunity and Vaccines
adam.thomas@burnet.edu.au

Professor James Beeson
Head, Malaria Immunity and Vaccines Laboratory
chrissie.collins@burnet.edu.au (EA)

Jo-Anne Chan
PEOPLE
James Beeson
PEOPLE
Adam Thomas
PEOPLE

More Student Projects

Collateral damage: how viral infections impact our innate immune system

Defining the long-term impacts of viral infections on innate immune cells such as monocytes and NK c...

STUDENT PROJECT
Exposure to hepatitis C among anabolic-androgenic steroid injectors in Victoria

Recruiting participants and measuring sero-prevalence of hepatitis C among people injecting steroids...

STUDENT PROJECT

burnet.edu.au/studentprojects

View projects

Why study at Burnet?

When you study at Burnet, you broaden your impact working across our three Institute-wide programs: Disease Elimination; Health Security and Pandemic Preparedness; Maternal, Child and Adolescent Health.

Train with internationally recognised experts in a structured student support system, and gain a holistic research experience along the way.

Find out more Student Projects

Study at Burnet. Broaden your impact.

burnet.edu.au/study